Clinicopathological value of somatostatin type 2A and estrogen receptor immunoreactivity in human breast carcinoma

By Pilichowska Monika   Kimura Noriko   Suzuki Akihiko   Yoshida Ryuichi   Schindler Marcus   Nagura Hiroshi  

Endocrine Pathology, Vol. 12, Iss. 1, 2001-03 ,pp. : 55-61

Humana Press, Inc

Access to resources Recommend Favorite

Somatostatin Type 2A Receptor Immunoreactivity in Human Pancreatic Adenocarcinomas

By Pilichowska M.   Kimura N.   Schindler M.   Kobari M.  

Endocrine Pathology, Vol. 12, Iss. 2, 2001-06 ,pp. : 147-155

Humana Press, Inc

Access to resources Recommend Favorite

Somatostatin Receptor Type 2 (SSTR2) in Bronchopulmonary Carcinoids

By Fassan Matteo   Rea Federico   Clemente Roberto   Rizzardi Giovanna   Pizzi Marco   Giacomelli Luciano   Rugge Massimo  

Endocrine Pathology, Vol. 21, Iss. 3, 2010-09 ,pp. : 204-205

Humana Press, Inc

Access to resources Recommend Favorite

Relationship between mammaglobin expression and estrogen receptor status in breast tumors

By Guan Xiao-feng   Hamedani Mohammad   Adeyinka Adewale   Walker Christina   Kemp Angela   Murphy Leigh   Watson Peter   Leygue Etienne  

Endocrine Journal, Vol. 21, Iss. 3, 2003-08 ,pp. : 245-250

Humana Press, Inc

Access to resources Recommend Favorite

Differential Expression of the Five Somatostatin Receptor Subtypes in Human Benign and Malignant Insulinomas – Predominance of Receptor Subtype 4

By Portela-Gomes Guida   Stridsberg Mats   Grimelius Lars   Rorstad Otto   Janson Eva  

Endocrine Pathology, Vol. 18, Iss. 2, 2007-05 ,pp. : 79-85

Humana Press, Inc

Access to resources Recommend Favorite